ConductScience.org, home

Paper34811367

A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems.

Packer M and 4 others. Nat Commun, 2021. Cited by 211 papers, by iCite.

Cite this record

ConductScience Library. A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems. Papers, record 34811367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34811367

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems.
PubMed
Journal
Nat Commun
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
211
iCite
Relative citation ratio, by iCite
12.4
iCite
Revised in PubMed
2021-12-14
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Packer MMeredith
2Gyawali DDipendra
3Yerabolu RRavikiran
4Schariter JJoseph
5White PPhilhttps://orcid.org/0000-0002-6078-9061

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug Delivery SystemsMajor topic
LiposomesMajor topic
NanoparticlesMajor topic
RNA, MessengerMajor topic
Vaccine PotencyMajor topic
Aldehydes
Chromatography, Liquid
Humans
Ions
Lipids
Nucleosides
Oxidation-Reduction
Protein Biosynthesis
RNA Stability
mRNA Vaccines

Source PubMed

Download CSV of topics

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111139637RNA analysis by ion-pair reversed-phase high performance liquid chromatography.Nucleic Acids Res2001https://conductscience.org/library/papers/11139637PubMed
232093140Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives.Nanomaterials (Basel)2020https://conductscience.org/library/papers/32093140PubMed
323792630Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape.Nat Biotechnol2013https://conductscience.org/library/papers/23792630PubMed
433321139Addressing the Cold Reality of mRNA Vaccine Stability.J Pharm Sci2021https://conductscience.org/library/papers/33321139PubMed
533378609Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.N Engl J Med2021https://conductscience.org/library/papers/33378609PubMed
629323295Alcohol and endogenous aldehydes damage chromosomes and mutate stem cells.Nature2018https://conductscience.org/library/papers/29323295PubMed
710737906Chemical stability of nucleic acid-derived drugs.J Pharm Sci2000https://conductscience.org/library/papers/10737906PubMed
830705318HPLC methods for purity evaluation of man-made single-stranded RNAs.Sci Rep2019https://conductscience.org/library/papers/30705318PubMed
930846391Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery.Mol Ther2019https://conductscience.org/library/papers/30846391PubMed
1033660201Nanoparticle-Mediated Cytoplasmic Delivery of Messenger RNA Vaccines: Challenges and Future Perspectives.Pharm Res2021https://conductscience.org/library/papers/33660201PubMed
1132637598Impact of mRNA chemistry and manufacturing process on innate immune activation.Sci Adv2020https://conductscience.org/library/papers/32637598PubMed
1219239894The many pathways of RNA degradation.Cell2009https://conductscience.org/library/papers/19239894PubMed
1333301246Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.N Engl J Med2020https://conductscience.org/library/papers/33301246PubMed
1433295773Enhanced Delivery of siRNA to Retinal Ganglion Cells by Intravitreal Lipid Nanoparticles of Positive Charge.Mol Pharm2021https://conductscience.org/library/papers/33295773PubMed
158746443Factors affecting DNA damage caused by lipid hydroperoxides and aldehydes.Free Radic Biol Med1996https://conductscience.org/library/papers/8746443PubMed
1620584607N-demethylation of N-methyl alkaloids with ferrocene.Bioorg Med Chem Lett2010https://conductscience.org/library/papers/20584607PubMed
1733815564Role of nanotechnology behind the success of mRNA vaccines for COVID-19.Nano Today2021https://conductscience.org/library/papers/33815564PubMed
1826889757Bioinspired Alkenyl Amino Alcohol Ionizable Lipid Materials for Highly Potent In Vivo mRNA Delivery.Adv Mater2016https://conductscience.org/library/papers/26889757PubMed
1929433939Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency.Mol Ther2018https://conductscience.org/library/papers/29433939PubMed
2033195094Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy.Front Chem2020https://conductscience.org/library/papers/33195094PubMed

See all 29 referencesDownload CSV of references

Cited by127

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 211 citations.

PMIDTitleJournalYearIn PapersSource
42975285Poly(acrylamido) PEG-Alternative Lipids Rescue mRNA Efficacy during Repeated Dosing and Enhance Immune Cell Delivery.ACS Nano2026https://conductscience.org/library/papers/42975285PubMed
42916086Boosting Ligand-Mediated Hepatic mRNA Delivery and Gene Editing Through Coordinated Pairing of Polyethylene Glycol-Modified Lipids.ACS Nano2026https://conductscience.org/library/papers/42916086PubMed
42908836pSIM: A next generation in vitro mRNA potency assay.Mol Ther Adv2026https://conductscience.org/library/papers/42908836PubMed
42806112Accelerated discovery of thermostable mRNA-lipid nanoparticle vaccines using data-efficient AI.Nat Biotechnol2026https://conductscience.org/library/papers/42806112PubMed
42791758Preparation of Targeted Delivery Materials and Their Application in Animal Production.Animals (Basel)2026https://conductscience.org/library/papers/42791758PubMed
42764981Lipid nanoparticles as active biointerfaces: From membrane interaction to systemic dysregulation.Acta Pharm Sin B2026https://conductscience.org/library/papers/42764981PubMed
42683374Amine oxide lipid nanoparticles for delivery of cyclic dinucleotides.Natl Sci Rev2026https://conductscience.org/library/papers/42683374PubMed
42653382Critical Evaluation of Key Methods for RNA Quantification.Int J Mol Sci2026https://conductscience.org/library/papers/42653382PubMed
42627629Comprehensive Analytical Characterization of mRNA Influenza Vaccine Under Stress Conditions: Implications for Stability and Quality Control.Pharm Res2026https://conductscience.org/library/papers/42627629PubMed
42593721Critical chemistry manufacturing and controls considerations for mRNA lipid nanoparticle translation.Discov Nano2026https://conductscience.org/library/papers/42593721PubMed
42539106Post-loading ribonucleic acid into lipid nanoparticle carriers.bioRxiv2026https://conductscience.org/library/papers/42539106PubMed
42523296Peptide additives reprogram the lipid nanoparticle corona and enhance gene delivery in a serum-free environment for lung epithelium.bioRxiv2026https://conductscience.org/library/papers/42523296PubMed
42514871Analytical Characterization and Stability Assessment of RNA-Based Vaccines.Pharmaceutics2026https://conductscience.org/library/papers/42514871PubMed
42506657Possible Mechanisms of mRNA-LNP Degradation: A Comprehensive Review.Vaccines (Basel)2026https://conductscience.org/library/papers/42506657PubMed
42441759Ligand-Mediated Reprogramming Redirects Liver-Tropic Ionizable Lipid Nanoparticles for Lung-Selective mRNA Delivery.Angew Chem Int Ed Engl2026https://conductscience.org/library/papers/42441759PubMed
42342874Immunological mechanisms of mRNA vaccines for infectious diseases.Nature2026https://conductscience.org/library/papers/42342874PubMed
42283697Storage Buffer Composition Impacts Internal Structure, Freeze-Thaw Stability, and Transfection Efficiency of mRNA-Lipid Nanoparticles.ACS Nano2026https://conductscience.org/library/papers/42283697PubMed
42243120Antioxidant lipid nanoparticles enhance mRNA stability for regeneration therapy and gene editing.Nat Commun2026https://conductscience.org/library/papers/42243120PubMed
42198337Delivery of mRNA Therapeutics Beyond Infectious Diseases: Design Innovations and Applications in Oncology, Cardiovascular, and Rare Genetic Diseases.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42198337PubMed
42198221Emerging Non-Conventional Approaches in mRNA-LNP Formulation for Therapeutic Applications.Pharmaceutics2026https://conductscience.org/library/papers/42198221PubMed

See all 127 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
EPO2056PubTator's text mininghttps://conductscience.org/library/genes/2056

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34811367

GET https://conductscience.org/api/papers/v1/34811367/references?page=2